Beam Therapeutics Inc
NASDAQ:BEAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
N
|
Nano One Materials Corp
SWB:LBMB
|
CA |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
A
|
Alphabet Inc
XETRA:ABEC
|
US |
|
Grifols SA
MAD:GRF
|
ES |
|
L
|
Lee & Man Paper Manufacturing Ltd
XMUN:LMP
|
HK |
|
Fujitsu General Ltd
TSE:6755
|
JP |
|
Franchise Group Inc
F:3HC
|
US |
|
SAP SE
OTC:SAPGF
|
DE |
|
G
|
GEA Group AG
XMUN:G1A
|
DE |
|
N
|
Natwest Group PLC
XHAM:RYS1
|
UK |
|
D
|
DTE Energy Co
F:DGY
|
US |
|
BKW AG
SIX:BKW
|
CH |
|
Global Education Communities Corp
OTC:GECSF
|
CA |
|
S
|
Sovereign Metals Ltd
OTC:SVMLF
|
AU |
|
F
|
First Solar Inc
DUS:F3A
|
US |
|
W
|
WPP PLC
XMUN:0WP
|
UK |
|
V
|
Vale Indonesia Tbk PT
XMUN:XT3B
|
ID |
Bankruptcy Probability
Beam Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Beam Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
194.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Beam Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Beam Therapeutics Inc has total debt of 100.2m USD. This includes both short-term (0 USD) and long-term (100.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
